Find and Pitch Jounalists, Get Your Story Covered

Tags: Front Page Eater at Home Martha Week international engine of the year ford gt

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 days ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 2 months ago STAT+: Pharmalittle: We’re reading about an Amgen obesity drug, a Senate bill on shortages, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 7 months ago STAT+: Pharmalittle: We’re reading about a GLP-1 side effect, U.K. clinical trial transparency, and more - 8 months ago STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more - 8 months ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - 8 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 9 months ago STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages - 9 months ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - 10 months ago STAT+: Pharmalittle: We’re reading about a GSK deal, a probe into inhaler prices, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 10 months ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - 11 months ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - 11 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 12 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: Novo Nordisk sees “significantly” more Wegovy in the U.S. next year; U.S. pharma layoffs skyrocket - about 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - about 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - about 1 year ago STAT+: Pharmalittle: China arrests an Astellas exec accused of spying; weight-loss drugs are being tested in children - about 1 year ago STAT+: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024 - about 1 year ago STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - about 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - about 1 year ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	AstraZeneca falls on reports of Chinese probe - 8 days ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs - 9 days ago Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M - about 1 month ago Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency - 3 months ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 10 days ago 2024 PharmaVoice 100s: Tech and AI Wizards - 17 days ago BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 3 months ago BMS’ long-standing leukemia blockbuster stares down its first generic - 4 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 6 months ago
5	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	2024 PharmaVoice 100s: Trailblazers - 29 days ago 2024 PharmaVoice 100s: Standout Leaders - about 1 month ago Amylyx’s CEOs on their ALS setback and quest to revamp the pipeline - 4 months ago Up-and-comers look for an edge in the bustling ADC field - 5 months ago Where competition is heating up in pharma - 6 months ago Behind a big-name rare disease biotech, an exec draws from personal experience - 9 months ago Astellas’ science chief on the leap into new technologies - 9 months ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - 10 months ago 3 standout digital innovations in pharma this year - 12 months ago PharmaVoice 100s: Entrepreneurs - about 1 year ago
6	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacist Spotlight: Anjeza Fero, PharmD, RPh - 2 months ago Product News: August 2024 - 3 months ago Pharmacist Spotlight: Cassandra Esperant, PharmD, AAHIVP - 4 months ago Condition Watch, June 2024 - 5 months ago June 2024 Products Column - 5 months ago Pharmacist Spotlight: Amina Abubakar, PharmD, AAHIVP - 5 months ago
7	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Dr Andriy Krendyukov - 7 months ago Marina Passarell - 8 months ago David Lawrence - 8 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	AstraZeneca Caps Inhaled Respiratory Portfolio at $35 For Eligible Patients With Asthma, COPD - 8 months ago
9	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	April 2024 - 8 months ago 2024 - 10 months ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline - 8 months ago STAT+: Startup launches with $245 million for twice yearly asthma treatment - about 1 year ago

Journalists covering Aspire Pharma